Stocktoria
CYTOKINETICS INC CYTK
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-04-29
CYTOKINETICS INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Malik Fady Ibraham | EVP Research & Development | 2026-06-23 | Option exercise | 3,500 | $7.80 |
| Malik Fady Ibraham | EVP Research & Development | 2026-06-23 | Sell | 3,500 | $79.51 |
| Blum Robert I | President & CEO | 2026-06-15 | Sell | 7,500 | $70.46 |
| Malik Fady Ibraham | EVP Research & Development | 2026-06-09 | Option exercise | 3,500 | $7.80 |
| Malik Fady Ibraham | EVP Research & Development | 2026-06-09 | Sell | 3,500 | $67.98 |
| Kaye Edward M. MD | director | 2026-06-01 | Sell | 2,933 | $76.09 |
| Callos Andrew | EVP, Chief Commercial Officer | 2026-06-01 | Option exercise | 15,000 | $23.26 |
| Callos Andrew | EVP, Chief Commercial Officer | 2026-06-01 | Sell | 15,000 | $74.08 |
Source: SEC EDGAR filings · CIK 0001061983 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.